FLT3-ITD Targeted Therapy in Fit AML Patients
FLT3-ITD Targeted Therapy in Fit AML Patients
Not yet recruiting · NCT07425808 · Registry updated 2026-02-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FLT3-ITD Targeted Therapy in Fit AML Patients | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 2 / Phase 3 | 2026-02-23 | NCT07425808 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Astellas Pharma Inc | 43 |
| European Organisation for Research and Treatment of Cancer - EORTC | 54 |
| Fondazione GIMEMA | 1 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||